Structure Therapeutics Inc
Exchange: NASDAQSector: HealthcareIndustry: Biotechnology
Structure Therapeutics Inc
Current Price
$38.69
-2.89%Profile
Valuation (TTM)
Market Cap$2.74B
P/E-16.07
EV—
P/B1.81
Shares Out70.77M
P/Sales—
Revenue$0.00
EV/EBITDA—
Structure Therapeutics Inc (GPCR) Stock Analysis
Market Cap$2.74B
Current Price$38.69
P/E Ratio-16.07
Forward P/E—
PEG Ratio-0.54
EPS$-2.40
Book Value$21.43
P/B Ratio1.81
GPCR Financial Charts
FCF vs CAPEX
FCFCAPEX
Cash vs Debt
Net Cash: 793M
Revenue
—
FY20
—
FY21
—
FY22
—
FY23
—
FY24
—
FY25
Net Income
—
FY20
—
FY21
—
FY22
—
FY23
—
FY24
—
FY25
GPCR 52-Week Range
$16.20
$93.79
50-Day MA: $48.28200-Day MA: $45.74
Did you know?
Price sits at 29% of its 52-week range.
Structure Therapeutics Inc (GPCR) Financial Summary
Structure Therapeutics Inc (GPCR) is a Healthcare company in the Biotechnology industry, listed on NASDAQ. The stock currently trades at $38.69 with a market capitalization of $2.74B.
Key valuation metrics include a P/E ratio of -16.07, price-to-book ratio of 1.81, and EPS of $-2.40. and return on equity of -11.2%.
GPCR Key Financial Metrics
| Metric | Value |
|---|---|
| Market Cap | $2.74B |
| P/E Ratio | -16.07 |
| EPS | $-2.40 |
| P/B Ratio | 1.81 |
| Return on Equity | -11.2% |
| Debt/Equity | 0.00 |
GPCR Revenue & Earnings History
| Year | Revenue | Net Income |
|---|---|---|
| FY20 | $0.00 | $-15.88M |
| FY21 | $0.00 | $-40.01M |
| FY22 | $0.00 | $-51.32M |
| FY23 | $0.00 | $-89.62M |
| FY24 | $0.00 | $-122.53M |
| FY25 | $0.00 | $-141.20M |
About Structure Therapeutics Inc
Structure Therapeutics Inc
GPCR Free Cash Flow
Structure Therapeutics Inc generated $-225.81M in trailing twelve-month free cash flow, representing an FCF yield of -8.25%. This low FCF yield may reflect heavy reinvestment or growth spending.
GPCR Shares Outstanding
Structure Therapeutics Inc has 0.07 billion shares outstanding at a share price of $38.69, giving it a market capitalization of $2.74B.